Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02302521 · ClinicalTrials.gov registry record

Motion Immune Magnetic Resonance Imaging (MRI)

A clinical trial of Parkinson's Disease, sponsored by Duke University.

Completed
Registry status
16
Enrollment target
1
Study location

NCT02302521 is a study of Parkinson's Disease that has completed, run by Duke University. The registered enrollment target is 16 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02302521, a study of Parkinson's Disease, has completed, sponsored by Duke University.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate our recently developed MRI reconstruction strategy for producing artifact-free neuro and abdominal MRI data. The new reconstruction strategies, including 1) REKAM and 2) MUSE, are capable of effectively removing motion-related artifacts resulting from global and local motion during neuro and free-breathing abdominal MRI scans, without modifying the MRI pulse sequences and protocols that are currently used in clinical scans. The study team aims to recruit 60 subjects across multiple challenge patient populations: 10 healthy young adults (age 20-30) and 10 healthy older adults (aged 50-70) for abdominal MRI, as well as 20 tremor dominant PD patients and 20 children (age 4-8) for brain MRI scans. There are no known risks in taking MRIs and a unique code will be assigned to each participant to protect their PHI.

Conditions Studied

Parkinson's Disease

Interventions

  • DEVICE Multiplex Sensitivity Encoding (MUSE)

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2015-05-28
Est. Completion 2016-11-26

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02302521

The ClinicalTrials.gov registry entry for NCT02302521 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Multiplex Sensitivity Encoding (MUSE) is the first listed.

NCT02302521 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02302521 about?

NCT02302521 is a clinical study titled "Motion Immune Magnetic Resonance Imaging (MRI)". The purpose of this study is to evaluate our recently developed MRI reconstruction strategy for producing artifact-free neuro and abdominal MRI data. The new reconstruction strategies, including 1) REKAM and 2) MUSE, are capable of effectively removing motion-related artifacts resulting from global ...

What is the current status of trial NCT02302521?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2015-05-28. Estimated completion is 2016-11-26.

What conditions does trial NCT02302521 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT02302521?

The interventions under investigation include: Multiplex Sensitivity Encoding (MUSE) (DEVICE).

Who is sponsoring clinical trial NCT02302521?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02302521 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.